找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology; Seth Kwabena Amponsah,Yashwant V. Pathak Book 2022 The Editor(s) (

[复制链接]
楼主: 鸟场
发表于 2025-3-23 13:35:38 | 显示全部楼层
Therapeutic Drug Monitoring (TDM) and Toxicological Studies in Alternative Biological Matrices,herapeutic drug monitoring (TDM) have, on the other hand, remained underappreciated. TDM has the potential to enhance patient outcomes while also lowering healthcare expenditures due to its unambiguous dose-response correlations. Two new approaches to TDM have emerged in recent years: target concent
发表于 2025-3-23 16:47:20 | 显示全部楼层
发表于 2025-3-23 20:07:47 | 显示全部楼层
Reducing Toxicity in Critically Ill Patients by Using Therapeutic Drug Monitoring,ualization, we can minimize the toxicity in critically ill patients. These days, the patient and organism complexity demand precision dosing which can be achieved through therapeutic drug monitoring (TDM) services. TDM has proven to be an effective approach for dose individualization. Conventionally
发表于 2025-3-24 00:32:40 | 显示全部楼层
发表于 2025-3-24 03:08:18 | 显示全部楼层
发表于 2025-3-24 09:08:56 | 显示全部楼层
发表于 2025-3-24 12:44:49 | 显示全部楼层
Therapeutic Drug Monitoring and Toxicology: Relevance of Measuring Metabolites,taining drug concentrations below toxic levels. Although TDM has predominantly focused on determining the level of the parent drug compound in order to guide the dosing regimen, it is important to consider that some drugs are inactive in their parental forms and only their metabolites have therapeut
发表于 2025-3-24 16:54:32 | 显示全部楼层
Recent Advances in Nanosensors for Therapeutic Drug Monitoring (TDM),rials and nanotechnology for therapeutic drug monitoring (TDM) in order to meet the urgent need of measuring drug concentrations in biological matrices like plasma, serum, saliva, or urine, at a lower cost and within a shorter time period than traditional immunoassays or chromatographic methods. Dev
发表于 2025-3-24 21:27:12 | 显示全部楼层
,Organ Toxicity by Immunosuppressive Drugs in Solid Organ Transplantation,nction and provides improved quality of life together with its cost-effectiveness. During perioperative and post-transplant periods, organ transplant recipients receive immunosuppressive therapy, which reduces the high risk of allograft rejection, minimizes infections, improves allograft quality, an
发表于 2025-3-25 01:06:11 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-15 02:57
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表